1. 18PCombination treatment with the PARP inhibitor niraparib and chemotherapeutics in a preclinical model of KRAS/BRAF mutated colorectal cancer cell lines across the four consensus molecular subtypes. (23rd October 2018) Authors: Vitiello, P P; Cardone, C; Ciardiello, D; Belli, V; Matrone, N; Borrelli, C; Poliero, L; De Falco, V; Giunta, E F; Vitale, P; Zanaletti, N; Tirino, G; Troiani, T; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 25PFunctional inhibition of TGF-β in colorectal cancer cells and its interaction with AXL receptor. (23rd October 2018) Authors: Ciardiello, D; Martini, G; Matrone, N; Belli, V; Vitiello, P P; Cardone, C; Ciaramella, V; Barra, G; Poliero, L; Borrelli, C; Troiani, T; Melisi, D; Morgillo, F; Giunta, E F; De Falco, V; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2OReceptor tyrosine kinase dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated colorectal cancer cell lines. (23rd October 2018) Authors: Vitiello, P P; Cardone, C; Ciardiello, D; Barra, G; Matrone, N; Belli, V; Martini, G; Poliero, L; Borrelli, C; Terminiello, M; Troiani, T; Morgillo, F; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 598PMacrophage migration inhibitory factor overexpression is a mechanism of acquired resistance to anti-EGFR inhibitor cetuximab in human colorectal cancer cell line. (23rd October 2018) Authors: Matrone, N; Chambery, A; Russo, R; Pedone, P V; Belli, V; Napolitano, S; Martinelli, E; Giunta, E F; De Falco, V; Zanaletti, N; Vitale, P; Terminiello, M; Cardone, C; Ciardiello, F; Troiani, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 66PDual inhibition of TGF-β and AXL as a novel treatment for colorectal cancer. (1st October 2019) Authors: Ciardiello, D; Belli, V; Cardone, C; Vitiello, P P; Martini, G; Poliero, L; Borrelli, C; Arrichiello, G; Ciaramella, V; Matrone, N; Barra, G; De Falco, V; Giunta, E F; Morgillo, F; Troiani, T; Terminiello, M; Melisi, D; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 96PAXL has a prognostic role in metastatic colorectal cancer (mCRC) and is a predictive biomarker of lack of efficacy of chemotherapy (CT) + cetuximab in RAS wild type (WT) patients (pts). (23rd October 2018) Authors: Cardone, C; Blauensteiner, B; Moreno-Viedma, V; Paul, M C; Martini, G; Vitiello, P P; Ciardiello, D; Borrelli, C; Poliero, L; Vitale, P; Zanaletti, N; Famiglietti, V; Rachiglio, A M; Rizzi, D; Maiello, E; Latiano, T P; Normanno, N; Sibilia, M; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Diagnosis and management of diabetic autonomic neuropathy. Issue 6384 (2nd July 1983) Authors: Bellavere, F; Bosello, G; Fedele, D; Cardone, C; Ferri, M Journal: BMJ Issue: Volume 287:Issue 6384(1983) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-326Clinical practice use of liquid biopsy to identify RAS/BRAF mutational status in patients with metastatic colorectal cancer: A single institution experience. (2nd July 2019) Authors: Falco, V De; Vitiello, P; Giunta, E; Ciardiello, D; Stefania, N; Cardone, C; Vitale, P; Zanaletti, N; Terminiello, M; Poliero, L; Borrelli, C; Caputo, V; Arrichiello, G; Mattera Iacono, V; Marrone, F; Famiglietti, V; Martinelli, E; Ciardiello, F; Troiani, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-330Retrospective study of Regorafenib versus Trifluridine/Tipiracil efficacy in chemorefractory metastatic colorectal cancer patients: a single Italian institution real-life clinical data. (2nd July 2019) Authors: Vitale, P; Zanaletti, N; Vitiello, P; martinelli, e; Ciardiello, D; Falco, V De; Giunta, E; Poliero, L; Terminiello, M; Borrelli, C; Caputo, V; Arrichiello, G; Martini, G; Stefania, N; Famiglietti, V; Cardone, C; Ciardiello, F; Troiani, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PD-019Optimizing treatment with anti-epidermal growth factor receptor drugs for patients with metastatic colorectal cancer: novel mechanisms of resistance beyond RAS. (2nd July 2019) Authors: Cardone, C; Blauensteiner, B; Moreno-Viedma, V; Paul, M; Martini, G; Troiani, T; Vitiello, P; Ciardiello, D; Poliero, L; Borrelli, C; Rachiglio, A; Rizzi, D; Maiello, E; Latiano, T; Normanno, N; Sibilia, M; Ciardiello, F; Martinelli, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗